UBS OCONNOR LLC - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 57 filers reported holding AMRYT PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$29,160,000
-99.8%
2,000,0000.0%0.90%
+240.3%
Q3 2022$13,840,000,000
-1.0%
2,000,0000.0%0.26%
+28.3%
Q2 2022$13,980,000,000
-35.0%
2,000,000
+0.5%
0.20%
-1.0%
Q4 2021$21,492,000,000
-10.7%
1,990,0000.0%0.21%
+9.5%
Q3 2021$24,059,000,000
-0.3%
1,990,0000.0%0.19%
-12.1%
Q2 2021$24,139,000,000
-12.9%
1,990,0000.0%0.22%
-46.1%
Q1 2021$27,721,000,000
-1.6%
1,990,0000.0%0.40%
-30.7%
Q4 2020$28,178,000,0001,990,0000.58%
Other shareholders
AMRYT PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders